PRKACB and liver cancer: HULC, which is significantly upregulated in hepatocellular carcinoma, can reduce the expression and activity of miR-372 in liver cancer, which derepresses the translation of its target gene PRKACB and induces phosphorylation of the cAMP response element binding protein in liver cancer (Wang et al., 2010).